SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Hugh Bett1/19/2025 8:53:07 PM
2 Recommendations

Recommended By
Arran Yuan
easygoer

   of 39305
 
Methylene Blue may be one of the most researched compounds currently in medicine. It was nominated by the National Cancer Institute for carcinogenicity testing due to its many uses and lack of long-term safety data.

Methylene Blue has long been revered in medical intervention due to its unique chemical structure and wide array of uses. But how in the world did this blue dye make the jump from textile dye to medical wonder?

Methylene Blue in Cancer Therapy: A Cancer Revolution
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News